Anticonvulsive and antiallergic/antiasthmatic pyrazolo-[3,4-d]py

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544262, A61K 31519, C07D48704

Patent

active

060544600

ABSTRACT:
The invention relates to pyrazolo[3,4d]pyrimidin-4(5H)-ones and pyrazolo[3,4-d]pyrimidine-4(5H)-thiones and their tautomers and pharmaceutically acceptable salts, which contain a benzyl radical in the 2-position, processes for their preparation and their use as medicaments, in particular for the treatment of epilepsies of various forms and of allergic/asthmatic diseases.

REFERENCES:
Gatta, F. et al., "Pyrazolo [3,4-D]pyrimidines Related to Lonidamine", J. Heterocyclic Chem., vol. 26, pp 613, 1989.
El Hedi Jellali, M. et al., "Acylation and alkylation of 4-aminopyrazolo [3,4-d] Pyrimidine", Tetrahedron, vol. 31, pp 587, 1975.
Eisenacher, Th. et al., "Ueber Neue Pyrazolverbindungen: 6.Mitteilung: Pyrazolo [3,4-d] pyrimidinylessigsaurederivate", Pharmazie Bd. 46, Nr. 10, 1991.
Eisenaecher et al. New pyrazole compounds. Pharmazie 46(10), 747-8, 1991.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Anticonvulsive and antiallergic/antiasthmatic pyrazolo-[3,4-d]py does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anticonvulsive and antiallergic/antiasthmatic pyrazolo-[3,4-d]py, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anticonvulsive and antiallergic/antiasthmatic pyrazolo-[3,4-d]py will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-993592

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.